Exact Mass: 663.3466

Exact Mass Matches: 663.3466

Found 103 metabolites which its exact mass value is equals to given mass value 663.3466, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

KOdiA-PC

1-Palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine

C32H58NO11P (663.3747)

Nelfinavir mesylate

C33H49N3O7S2 (663.3012)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

Phe Arg Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)

Phe Arg Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)

Phe Trp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)

Arg Phe Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)

Arg Phe Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)

Arg Arg Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)

Arg Arg Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)

Arg Trp Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)

Arg Trp Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)

Arg Tyr Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H41N7O8 (663.3016)

Trp Phe Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)

Trp Arg Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)

Trp Arg Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)

Tyr Arg Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H41N7O8 (663.3016)

Tyr Tyr Arg Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H41N7O8 (663.3016)

Tyr Tyr Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C33H41N7O8 (663.3016)

RLNDF

Arg-Leu-Asn-Asp-Phe

C29H45N9O9 (663.334)

IFDRN

Ile Phe Asp Arg Asn

C29H45N9O9 (663.334)

RVFDK

Arg-Val-Phe-Asp-Lys

C30H49N9O8 (663.3704)

PKODiA-PC

1-hexadecanoyl-2-(5-oxo-7-carboxy-6E-heptenoyl)-sn-glycero-3-phosphocholine

C32H58NO11P (663.3747)

OHOHA-PS

1-(9Z-octadecenoyl)-2-(4-hydroxy-7-oxo-5E-heptenoyl)-sn-glycero-3-phosphoserine

C31H54NO12P (663.3383)

BQ-788 (sodium salt)

C34H50N5NaO7 (663.3608)

Fmoc-N-amido-PEG8-acid

C34H49NO12 (663.3255)

boc-val-pro-arg-amc hcl

C31H46ClN7O7 (663.3147)

16-alpha-hydroxygypsogenate-28-beta-D-glucoside

C36H55O11- (663.3744)

medicagenate-23-O-B-glucoside

C36H55O11- (663.3744)

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-22-thia-2,24-diazatricyclo[18.6.1.021,25]heptacosa-1(27),6,8,10,16,20,23,25-octaen-13-yl] (2R)-2-(cyclohexanecarbonylamino)propanoate

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-22-thia-2,24-diazatricyclo[18.6.1.021,25]heptacosa-1(27),6,8,10,16,20,23,25-octaen-13-yl] (2R)-2-(cyclohexanecarbonylamino)propanoate

C37H49N3O6S (663.3342)

1-Palmitoyl-2-(5-keto-6-octendioyl)-sn-glycero-3-phosphatidylcholine

C32H58NO11P (663.3747)

16alpha-hydroxygypsogenate 28-beta-D-glucoside

C36H55O11- (663.3744)

methyl (1R,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-2-oxo-21-oxa-17,24,29-triaza-9-azoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-3,5(18),19,30,32,34-hexaene-28-carboxylate

methyl (1R,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-2-oxo-21-oxa-17,24,29-triaza-9-azoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-3,5(18),19,30,32,34-hexaene-28-carboxylate

C40H47N4O5+ (663.3546)

(9Z)-17-hydroxyoctadec-9-enoate 17-O-(6-O-acetyl-beta-D-glucosyl)-(1->2)-beta-D-glucoside

C32H55O14- (663.3592)

Lnape 5:0/N-26:7

C36H58NO8P (663.39)

Lnape 26:7/N-5:0

C36H58NO8P (663.39)

Lnape 24:7/N-7:0

C36H58NO8P (663.39)

Lnape 7:0/N-24:7

C36H58NO8P (663.39)

(1S,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-28-methoxycarbonyl-21-oxa-17,29-diaza-9,24-diazoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-2,4,17,19,30,32,34-heptaen-2-olate

(1S,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-28-methoxycarbonyl-21-oxa-17,29-diaza-9,24-diazoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-2,4,17,19,30,32,34-heptaen-2-olate

C40H47N4O5+ (663.3546)

CID 168510856

C26H45N7O13 (663.3075)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]propanamide

C32H57NO13 (663.383)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]pentanamide

C32H57NO13 (663.383)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]heptanamide

C32H57NO13 (663.383)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]octanamide

C32H57NO13 (663.383)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]acetamide

C32H57NO13 (663.383)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]butanamide

C32H57NO13 (663.383)

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]hexanamide

C32H57NO13 (663.383)

(2S)-2-amino-3-[[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C34H50NO10P (663.3172)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C36H58NO8P (663.39)

[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H58NO8P (663.39)

[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H58NO8P (663.39)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C36H58NO8P (663.39)

1-Palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine

1-Palmitoyl-2-(5-keto-6-octendioyl)-sn-glycero-3-phosphatidylcholine

C32H58NO11P (663.3747)

PC(28:7)

PC(18:3_10:4)

C36H58NO8P (663.39)

PC 16:0/8:3;O3

C32H58NO11P (663.3747)

PC 16:1/8:2;O3

C32H58NO11P (663.3747)

PC 20:5/7:3;O

C35H54NO9P (663.3536)

PC 27:8;O

C35H54NO9P (663.3536)

LNAPE 30:8;O

C35H54NO9P (663.3536)

LNAPE 31:7

C36H58NO8P (663.39)

PE 16:0/11:3;O3

C32H58NO11P (663.3747)

PE 20:0/7:3;O3

C32H58NO11P (663.3747)

PE 20:1/7:2;O3

C32H58NO11P (663.3747)

PE 20:5/9:4;O2

C34H50NO10P (663.3172)

PE 22:5/8:3;O

C35H54NO9P (663.3536)

PE 22:6/7:3;O2

C34H50NO10P (663.3172)

PE 27:3;O3

C32H58NO11P (663.3747)

PE 29:9;O2

C34H50NO10P (663.3172)

PE 30:8;O

C35H54NO9P (663.3536)

LNAPS 26:2;O

C32H58NO11P (663.3747)

LNAPS 28:8

C34H50NO10P (663.3172)

PS O-18:0/8:3;O2

C32H58NO11P (663.3747)

PS O-25:4;O3

C31H54NO12P (663.3383)

PS O-26:3;O2

C32H58NO11P (663.3747)

PS P-18:0/7:3;O3

C31H54NO12P (663.3383)

PS P-18:0/8:2;O2

C32H58NO11P (663.3747)

PS P-18:1/7:2;O3

C31H54NO12P (663.3383)

PS P-18:1/8:1;O2

C32H58NO11P (663.3747)

PS 16:1/8:3;O3

C30H50NO13P (663.302)

PS 18:0/7:3;O2

C31H54NO12P (663.3383)

PS 18:1/7:2;O2

C31H54NO12P (663.3383)

PS 18:1/8:1;O

C32H58NO11P (663.3747)

PS 20:0/6:2;O

C32H58NO11P (663.3747)

PS 20:2/5:1;O2

C31H54NO12P (663.3383)

PS 22:1/4:1;O

C32H58NO11P (663.3747)

PS 24:4;O3

C30H50NO13P (663.302)

PS 26:2;O

C32H58NO11P (663.3747)

ST 26:5;O7;HexNAc

C34H49NO12 (663.3255)

ST 27:4;O6;HexNAc

C35H53NO11 (663.3618)

5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)

5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(sec-butyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)

(3s,6s,9s,15s,21s)-5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)

2-[2-({17-amino-6-[(3,4-dicarboxybutanoyl)oxy]-14,16-dihydroxy-5,9-dimethylheptadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C31H53NO14 (663.3466)

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

C31H49N7O9 (663.3592)

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-7-[2-(methylsulfanyl)ethyl]-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-7-[2-(methylsulfanyl)ethyl]-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

C32H57NO11S (663.3652)

(3r,6s,9s,15s,21s)-6,15-bis[(2s)-butan-2-yl]-5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)